Technology Management for High Blood Pressure
Technology-enabled Management Versus Usual Care for Blood Pressure
Recruiting
N/A
Interventional Study
Hypertension
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 30 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 200 (estimated)
- Sponsor
- Stanford University · Other
Who this trial is looking for
This trial is looking for adults with high blood pressure who own a smartphone. Participants will receive technology-based management to help control their blood pressure.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 30 and 90 years old.
- I own a smartphone.
- My office blood pressure is 140 mm Hg or higher.
- I take 2 or fewer blood pressure medications.
- I can increase the dose or add at least 2 types of blood pressure medications.
- I speak either English or Spanish.
You may not be able to join if
- I have heart failure with a reduced ejection fraction.
- I have end-stage renal disease.
- I am on renal replacement therapy.
- I am pregnant.
- I have had a heart attack or stroke in the last 6 months.
- I have been hospitalized for a hypertensive emergency in the last 6 months.
- I have had a solid organ transplant.
- I am enrolled in another clinical study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Two arm parallel randomized clinical trial
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 30-90 yrs.
* Smartphone ownership
* Office SBP: ≥ 140 mm Hg
* ≤ 2 current anti-HTN meds
* Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.…
Contacts